Core Viewpoint - The stock of Dermei Chemical has experienced a consecutive two-day limit-up, indicating strong market interest and potential growth driven by various factors [1] Group 1: Stock Performance - Dermei Chemical's stock reached a limit-up at 10:11 AM today, with a trading volume of 720 million yuan and a turnover rate of 18.35% [1] Group 2: Growth Drivers - The company's subsidiary is utilizing synthetic biology technology through a joint venture to implement biological enzyme methods, aligning with the low-carbon transition trend [1] - Dermei Chemical is investing in the quantum computing sector through an industrial fund, which is in line with cutting-edge technology trends [1] - The company's products are classified as bio-based materials, which resonate with national policies promoting green manufacturing, potentially benefiting from policy-driven expectations [1]
合成生物学+量子计算+生物基材料概念联动2连板!德美化工10时11分再度涨停,背后逻辑揭晓